UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells.

[1]  Y. Wu,et al.  TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion , 2010, British Journal of Cancer.

[2]  M. Diederich,et al.  UNBS1450 from Calotropis procera as a regulator of signaling pathways involved in proliferation and cell death. , 2009, Biochemical pharmacology.

[3]  F. Balkwill.  Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.

[4]  M. Montenarh,et al.  Cell cycle arrest in early mitosis and induction of caspase-dependent apoptosis in U937 cells by diallyltetrasulfide (Al2S4) , 2009, Apoptosis.

[5]  C. Reynolds,et al.  Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy , 2009, Clinical Cancer Research.

[6]  G. Chinnadurai,et al.  BH3-only proteins in apoptosis and beyond: an overview , 2008, Oncogene.

[7]  Serge Eifes,et al.  Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. , 2008, Biochemical pharmacology.

[8]  Gianluca Bontempi,et al.  Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity , 2008, Molecular Cancer Therapeutics.

[9]  B. Aggarwal,et al.  TNF: a master switch for inflammation to cancer. , 2008, Frontiers in bioscience : a journal and virtual library.

[10]  F. Lefranc,et al.  La pompe à sodium pourrait représenter une nouvelle cible pour le traitement des glioblastomes , 2008 .

[11]  B. Aggarwal,et al.  Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway. , 2008, Biochemical pharmacology.

[12]  R. Kiss,et al.  TARGETING THE α 1 SUBUNIT OF THE SODIUM PUMP TO COMBAT GLIOBLASTOMA CELLS , 2008, Neurosurgery.

[13]  R. Kiss,et al.  UNBS1450: A new hemi‐synthetic cardenolide with promising anti‐cancer activity , 2007 .

[14]  R. Kiss,et al.  The α1 subunit of the sodium pump could represent a novel target to combat non‐small cell lung cancers , 2007 .

[15]  T. Gilmore.  Introduction to NF-κB: players, pathways, perspectives , 2006, Oncogene.

[16]  R. Kiss,et al.  Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. , 2006, Neoplasia.

[17]  R. Kiss,et al.  The cardenolide UNBS1450 is able to deactivate nuclear factor κB–mediated cytoprotective effects in human non–small cell lung cancer cells , 2006, Molecular Cancer Therapeutics.

[18]  D. Steensma,et al.  On the TRAIL of a new therapy for leukemia , 2005, Leukemia.

[19]  D. Green,et al.  Connected to Death: The (Unexpurgated) Mitochondrial Pathway of Apoptosis , 2005, Science.

[20]  M. Galteau,et al.  Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. , 2004, Biochemical pharmacology.

[21]  G. Gores,et al.  Mcl-1 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Human Cholangiocarcinoma Cells , 2004, Cancer Research.

[22]  L. Larocca,et al.  Mutations of the BIK gene in human peripheral B‐cell lymphomas , 2003, Genes, chromosomes & cancer.

[23]  E. Henson,et al.  Increased expression of Mcl‐1 is responsible for the blockage of TRAIL‐induced apoptosis mediated by EGF/ErbB1 signaling pathway , 2003, Journal of cellular biochemistry.

[24]  A. Strasser,et al.  BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. , 2002, Journal of cell science.

[25]  P. Daniel,et al.  The kiss of death: promises and failures of death receptors and ligands in cancer therapy , 2001, Leukemia.

[26]  P. Hersey,et al.  Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types , 2000, FEBS letters.

[27]  L. Ghibelli,et al.  GSH extrusion and and the mitochondrial pathway of apoptotic signalling. , 2000, Biochemical Society transactions.

[28]  A. Strasser,et al.  Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. , 1999, Science.

[29]  R. Kiss,et al.  [The sodium pump could constitute a new target to combat glioblastomas]. , 2008, Bulletin du Cancer.

[30]  A. Mantovani,et al.  Cancer: Inflaming metastasis , 2008, Nature.

[31]  R. Kiss,et al.  The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. , 2007, The Journal of pathology.

[32]  N. Perkins,et al.  Integrating cell-signalling pathways with NF-kappaB and IKK function. , 2007, Nature reviews. Molecular cell biology.

[33]  T. Gilmore,et al.  Introduction to NF-kappaB: players, pathways, perspectives. , 2006, Oncogene.

[34]  Michael Karin,et al.  NF-kappaB: linking inflammation and immunity to cancer development and progression. , 2005, Nature reviews. Immunology.